Concepts (63)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Monoclonal Gammopathy of Undetermined Significance | 3 | 2024 | 176 | 1.040 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2021 | 1559 | 0.860 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2021 | 109 | 0.690 |
Why?
|
Paraproteinemias | 1 | 2022 | 251 | 0.640 |
Why?
|
Multiple Myeloma | 6 | 2025 | 5189 | 0.490 |
Why?
|
Central Nervous System Neoplasms | 1 | 2020 | 918 | 0.390 |
Why?
|
Venous Thrombosis | 1 | 2021 | 1319 | 0.380 |
Why?
|
Dexamethasone | 2 | 2025 | 1962 | 0.240 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2025 | 11858 | 0.220 |
Why?
|
Boron Compounds | 1 | 2025 | 195 | 0.210 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 9373 | 0.190 |
Why?
|
Glycine | 1 | 2025 | 671 | 0.190 |
Why?
|
Lebanon | 1 | 2020 | 246 | 0.160 |
Why?
|
Osteonecrosis | 1 | 2021 | 230 | 0.160 |
Why?
|
Mass Spectrometry | 1 | 2022 | 2194 | 0.120 |
Why?
|
Methotrexate | 1 | 2020 | 1719 | 0.110 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2022 | 1076 | 0.100 |
Why?
|
Incidence | 2 | 2021 | 21513 | 0.100 |
Why?
|
Infant | 2 | 2021 | 36426 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10727 | 0.070 |
Why?
|
Child, Preschool | 2 | 2021 | 42510 | 0.070 |
Why?
|
Transplantation, Autologous | 2 | 2023 | 2125 | 0.070 |
Why?
|
Health Personnel | 1 | 2021 | 3385 | 0.070 |
Why?
|
Survival Rate | 1 | 2020 | 12822 | 0.060 |
Why?
|
Prevalence | 1 | 2022 | 15828 | 0.060 |
Why?
|
Child | 3 | 2021 | 80568 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5379 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2022 | 5752 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2020 | 22228 | 0.050 |
Why?
|
Adolescent | 2 | 2021 | 88811 | 0.050 |
Why?
|
Male | 5 | 2025 | 363815 | 0.050 |
Why?
|
Humans | 12 | 2025 | 765926 | 0.050 |
Why?
|
Female | 5 | 2025 | 396141 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 29890 | 0.040 |
Why?
|
Plasma Cells | 1 | 2022 | 596 | 0.040 |
Why?
|
Cohort Studies | 1 | 2022 | 41680 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39228 | 0.040 |
Why?
|
Risk Factors | 2 | 2024 | 74850 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13446 | 0.040 |
Why?
|
Creatinine | 1 | 2023 | 1916 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2022 | 1527 | 0.030 |
Why?
|
Tumor Burden | 1 | 2022 | 1888 | 0.030 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2021 | 896 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2023 | 81537 | 0.030 |
Why?
|
Prospective Studies | 1 | 2020 | 54807 | 0.030 |
Why?
|
Stem Cell Transplantation | 1 | 2023 | 1600 | 0.030 |
Why?
|
Young Adult | 1 | 2021 | 59857 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2022 | 2838 | 0.030 |
Why?
|
Bone Marrow | 1 | 2022 | 2916 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2021 | 2155 | 0.020 |
Why?
|
Qualitative Research | 1 | 2021 | 3136 | 0.020 |
Why?
|
Public Health | 1 | 2021 | 2680 | 0.020 |
Why?
|
Disease Progression | 1 | 2025 | 13614 | 0.020 |
Why?
|
Genotype | 1 | 2021 | 13026 | 0.020 |
Why?
|
Algorithms | 1 | 2023 | 14064 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2021 | 16039 | 0.010 |
Why?
|
Obesity | 1 | 2024 | 13082 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2025 | 59496 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2025 | 65194 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 30192 | 0.010 |
Why?
|
Aged | 1 | 2025 | 171163 | 0.010 |
Why?
|
Middle Aged | 1 | 2025 | 223016 | 0.010 |
Why?
|
Adult | 1 | 2025 | 223088 | 0.010 |
Why?
|
Concepts
(63)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(40)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore